Table 1.

The effect of GZFLC drug serum on cell proliferation of human uterine leiomyoma cells.

Groups	Concentration (%)	Cases	OD value
			12 h	24 h	36 h	48 h	72 h
GZFLC	10	6	0.60 ± 0.05	0.75 ± 0.04	0.86 ± 0.04#	1.06 ± 0.02#	1.27 ± 0.04∗
	20	6	0.60 ± 0.025	0.72 ± 0.02#	0.84 ± 0.02#	1.00 ± 0.06#	1.39 ± 0.022#∗
	30	6	0.58 ± 0.02#	0.69 ± 0.02#	0.78 ± 0.02#	0.91 ± 0.02#	1.49 ± 0.02#∗
Negative control	10	6	0.63 ± 0.05	0.80 ± 0.03∗	0.99 ± 0.05∗	1.19 ± 0.02∗	1.25 ± 0.03∗
	20	6	0.66 ± 0.03	0.89 ± 0.03∗	1.11 ± 0.05∗	1.28 ± 0.07∗	1.30 ± 0.02∗
	30	6	0.67 ± 0.03	0.92 ± 0.02∗	1.20 ± 0.01∗	1.32 ± 0.01∗	1.33 ± 0.01∗
Blank control	—	6	0.61 ± 0.03	0.70 ± 0.04	0.83 ± 0.05	0.90 ± 0.09	0.85 ± 0.08

^∗Compared with blank control, P < 0.05.

^#Compared with negative control, P < 0.05.